Trial Profile
Open, randomised, crossover study assessing the effects of Lisdexamfetamine dimesylate on cytochrome P450 substrate pharmacokinetics in Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Dec 2017
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary) ; Caffeine; Dextromethorphan; Midazolam; Omeprazole
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacokinetics
- Sponsors Shire
- 17 Dec 2014 New trial record